Latest Breaking News On - Asahi kasei pharma ventures - Page 1 : vimarsana.com

Azafaros announces completion of 12-week Phase 2 RAINBOW study evaluating lead asset nizubaglustat in rare disease patients

Azafaros announces completion of 12-week Phase 2 RAINBOW study evaluating lead asset nizubaglustat in rare disease patients
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAsahi kasei pharmaAmber fennellAshley tappChris freitagRoberto giuglianiPorto alegreLeiden universityDrug administrationEuropean medicines agencyGenetics clinical research groupHealthcare products regulatory agencyMedical genetics clinical research groupHospital de clinicas porto alegreLead principal investigator

Azafaros to present data from PRONTO study in patients with GM1 and GM2 gangliosidoses at the 20th annual WORLDSymposium™

Azafaros to present data from PRONTO study in patients with GM1 and GM2 gangliosidoses at the 20th annual WORLDSymposium™
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoUnited kingdomAsahi kasei pharmaChristian freitagLeiden universityHealthcare products regulatory agencyEuropean medicines agencyDrug administrationMolecular geneticsLysosomal storageChief medical officerStates foodPediatric disease designationsDrug designationsTay sachs diseases

Glycomine Raises $68M in Series B Funding

Glycomine Raises $68M in Series B Funding
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Bali muralidharNiall odonnellPeter mcwilliamsJim trenkleAsahi kasei pharmaMission biocapitalGlycomine incNovo holdingsSan carlosSanofi venturesRivervest venture partnersAsahi kasei pharma venturesSanderling venturesChiesi venturesManaging partnerNiallo donnell

Glycomine Raises $35 Million to Advance Novel Treatment for Rare Glycosylation Disease

Glycomine Raises $35 Million to Advance Novel Treatment for Rare Glycosylation Disease
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United statesBali muralidharNiall odonnellPeter mcwilliamsJim trenkleAsahi kasei pharmaMission biocapitalNovo holdingsOrphan drugRare pediatric diseaseSanofi venturesRivervest venture partnersAsahi kasei pharma venturesSanderling venturesChiesi venturesNiallo donnell